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Lipedema: A Painful Adipose 
Tissue Disorder
Sara Al-Ghadban, Karen L. Herbst and Bruce A. Bunnell
Abstract
Lipedema is a painful fat disease of loose connective tissue usually misdiagnosed 
as lifestyle-induced obesity that affects ~10% of women of European descent as 
well as other populations. Lipedema is characterized by symmetric enlargement 
of the buttocks, hips, and legs due to increased loose connective tissue; arms are 
also affected in 80% of patients. Lipedema loose connective tissue is character-
ized by hypertrophic adipocytes, inflammatory cells, and dilated leaky blood and 
lymphatic vessels. Altered fluid flux through the tissue causes accumulation of 
fluid, protein, and other constituents in the interstitium resulting in recruitment 
of inflammatory cells, which in turn stimulates fibrosis and results in difficulty 
in weight loss. Inflammation and excess interstitial substance may also activate 
nerve fibers instigating the painful lipedema fat tissue. More research is needed to 
characterize lipedema loose connective tissue structure in depth, as well as the form 
and function of blood and lymphatic vessels. Understanding the pathophysiology 
of the disease will allow healthcare providers to diagnose the disease and develop 
treatments.
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1. Introduction
Loose connective tissue disorders include lipedema, Dercum’s disease (DD), 
familial multiple lipomatosis (FML) and multiple symmetric lipomatosis (MSL). 
All these disorders share many similarities with lipedema including painful lipo-
mas, obesity, fibrosis, a risk of developing lymphedema and difficulty in losing the 
abnormal fat through diet and exercise. There are clinical characteristics specific 
for lipedema, including the onset of the disease, fat location and associated health 
issues (Table 1) [1, 2].
Lipedema is often misdiagnosed as lifestyle-induced obesity that affects ~10% of 
women of European descent as well as other populations [3, 4]. Although both dis-
orders are considered inflammatory diseases due to the presence of increased mac-
rophages and hypertrophic adipocytes, there are significant differences between 
the two disorders. Among these is the location of the fat, primarily abdominal or 
spread widely over the body in obesity compared to the symmetric distribution in 
the lower extremities in lipedema, the texture of the skin (thin and soft in lipedema 
and thicker in obesity), easy bruising and pain upon the introduction of pressure in 
lipedema [5, 6].
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The focus of this review will be on the disease of lipedema, different stages and 
types, diagnosis and treatment, pathogenesis and current research in the field.
2. Lipedema
Lipedema also referred to as lipedema, is a painful loose connective tissue dis-
order first described in 1940 by Allen and Hines [7]. Lipedema is characterized 
by symmetric enlargement of the buttocks, hips and legs due to deposition of 
loose connective tissue that includes fascia, adipocytes, immune cells and other 
structures; arms are also affected in 80% of patients [3, 4]. Feet are typically 
spared, but ankle cuffs are often noted in advanced stages of lipedema where 
the risk of lymphedema is also high [8, 9]. Patients with lipedema experience 
mobility issues, psychosocial distress, anxiety, eating disorders, sleep apnea and 
depression [1, 10].
Lipedema is considered a hormone-related disorder affecting almost exclu-
sively women during puberty, childbirth or menopause. Case reports of men 
with lipedema have been described in literature. Men with lipedema have ele-
vated estrogen level and low to absent testosterone levels resulting in cirrhosis, 
gynecomastia and hypogonadism [11–13]. While the exact etiopathogenesis of 
this disease is unknown [10, 14], many studies have demonstrated that inflam-
matory cells, hypertrophic adipocytes, abnormal blood vessels and lymphatic 
dysfunction are associated with tissue damage and development of a fibrotic 
disease [14–17].
Characteristic Lipedema DD MSL FML MSL
Abnormal fat 
location
Legs, arms, 
abdomen
Global Upper; can 
be global
Arms, thighs, 
trunk, 
abdomen
Upper; can 
be global
Diet-resistant 
fat
Yes Yes Yes Yes Yes
Lipomas Yes Common Common in 
men
Common Common in 
men
Time fat 
change
Puberty; 3rd 
decade
Child-adult Adult; child 
rare
Child-adult Adult; child 
rare
Painful fat Yes Yes Not usually Lipoma Not usually
Sex 
predominance
Female Female Male Male = female Male
Lymphatic 
dysfunction
Yes Yes Yes Yes Yes
Prevalence Possibly 
common
Possibly 
common
Rare Rare Rare
Associated 
conditions
Lymphedema Autoimmune; 
diabetes
Neuropathy Moles; 
neuropathy
Neuropathy
Inheritance 
pattern
Autosomal 
dominant; 
incomplete 
penetrance
Autosomal 
dominant; 
sex-specific 
influence
Autosomal 
dominant or 
recessive
Autosomal 
dominant
Autosomal 
dominant or 
recessive
Modified from Ref. [1].
Table 1. 
Characteristics of loose connective tissue disorders.
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2.1 Stages of lipedema
Lipedema consists of three stages characterized by the texture of skin and tissue 
formation. Stage 1 involves smooth skin over pearl-sized nodules in a hypertrophic 
fat layer; Stage 2 has skin indentations over a hypertrophic fat structure of pearl-
to-apple-size masses; and Stage 3 includes pearl-sized nodules and much larger fat 
masses causing lobules of skin and fat to form mainly on the hips, thighs, and around 
the knees. Lymphedema, causing fluid accumulation in the limbs, may develop dur-
ing any stage of lipedema and is referred to as lipo-lymphedema [1, 3, 10, 18, 19].
Healthcare providers often misdiagnose women with lipedema as they do not 
take into account the disproportionate size of the legs compared to trunk especially 
in Stage 1 and 2 along with the inability to lose fat from areas affected by lipedema. 
It is possible to confuse women with Stage 3 lipedema as having lifestyle-induced 
obesity due to fat involving more areas of the body.
2.2 Types of lipedema
In addition to stages of lipedema, lipedema is also characterized by types deter-
mined by the area of the body that is affected. There are five types of lipedema; 
types I, II, and III are the most common. In Type I, fat is deposited in the areas of 
the buttocks and hips resembling saddle bags. In Type II, fat extends to the knees 
from the buttocks area with the formation of folds of fat around the inside of the 
knee. In Type III, fat spreads all over the lower body from the hips to the ankles. 
In Type IV, upper arms are affected causing difficulty in lifting the arm and stress 
on the shoulder. In Type V, fat is restricted to the lower legs. It is worth noting that 
patients with lipedema can clinically present with a mixture of types [3, 10].
2.3 Signs and symptoms
Pain, tenderness, bruising easily, symmetrical swelling of the legs, heaviness 
of affected limbs, burning sensations in the skin and fat, soft skin, negative stem-
mer’s sign and hypermobile joints are among the common symptoms observed in 
lipedema patients [2, 3, 6, 13]. Hypermobility in women with has been reported 
to contribute to joint damage and increase the risk of cardiovascular disease as 
seen in Ehlers Danlos Syndrome-Hypermobility Type (EDS-HT) with Beighton 
score higher than 5 [2, 3, 20, 21]. Thus, hypermobility causes structural changes 
in lipedema tissue resulting in increased fibrosis, dysfunction of blood vessels and 
accumulation of interstitial fluid.
Women with lipedema also experience emotional symptoms due to unexplained 
weight gain including embarrassment, anxiety and depression that impact their 
overall quality of life [22, 23]. Symptoms may progress in advanced stages of 
lipedema that might be associated with increased cardiovascular and renal diseases. 
A study conducted by Herbst el al. in 2015 provides a detailed list of symptoms 
experienced by lipedema patients [3].
2.4 Diagnosis and treatment of lipedema
Diagnosis of lipedema involves a comprehensive physical exam based on the 
criteria listed by Wold and colleagues in 1951, [4] medical and surgical history, list 
of medications that might affect weight or fluid retention and family history. A 
physical examination includes assessment of the enlarged lower extremities care-
fully noting the texture of the affected areas such as velvety soft skin that can be 
found in hypermobility, nodular fat, pain when applying pressure, tenderness upon 
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palpation and accumulation of fluid such as pitting or non-pitting edema which 
may indicate lymphedema [18, 24]. Bruising caused by increased capillary fragility 
[6], spider veins and telangiectasia showing on the surface of the skin due to venous 
insufficiency are also observed in lipedema patients [4, 10].
Although, there is no cure for lipedema, treatments like liposuction (tumescent 
and water jet) [25], complete decongestive therapy that includes manual lymphatic 
drainage [26, 27], compression garments, a healthy diet, physical activity, medica-
tions and supplements (statins, selenium, diosmin, amphetamines and butcher’s 
broom) have been shown to reduce pain, improve lymphatic function, decrease 
leakage from blood vessels, lessen inflammation and fibrosis and maintain a 
healthy gut [24, 28–34].
Liposuction is by far the most effective treatment to decrease the fibrotic 
lipedema fat and thereby maintain mobility which is essential for the welfare of 
women living with lipedema [35–37]. Water jet-assisted liposuction has been proven 
to be as effective as tumescent liposuction. Damage to the lymph vessels has not 
been show as evidenced in a histological study conducted by Stutz et al. on lipoaspi-
rates collected from lipedema patients [32]. Nevertheless, special care should be 
taken with lipo-lymphedema patients, where accumulated lymph and or fibrotic 
tissue should be removed first. Furthermore, follow-up and compression therapy 
are advised for successful and effective treatment.
Deep tissue massage has also been demonstrated to improve the quality of 
subcutaneous adipose tissue by decreasing pain, fibrosis and fat tissue in women 
with lipedema [29, 38].
Additionally, a healthy non-inflammatory diet is highly recommended, even 
though it will not reduce the lipedema tissue, but it might slow the progression of the 
disease by reducing inflammation and pain, lessen the swelling and ultimately improve 
quality of life. No one plan works for everyone but a ketogenic diet with low processed 
carbohydrate and mild physical exercises like walking, swimming, Pilates, yoga and 
other home excise programs are suggested by lipedema specialists. These activates will 
help the function of lymphatic pump and maintain a normal metabolism.
Finally, it is very important to detect and treat lipedema at early stages thus pre-
venting the complications that might occur due to the progression of disease. These 
complications comprise eating disorders, sleep apnea, diabetes mellitus, arthritis, 
hypertension, cellulitis, cardiac and renal disease.
3. Lipedema versus lymphedema
There are distinctive criteria for lipedema which are absent in lymphedema 
including a negative Stemmer’s sign, minimal pitting edema, thin skin, easy 
bruising, tenderness and pain [14, 39, 40]. Although lymphatic microaneurysms 
might develop in the later stages of lipedema leading to secondary lymphedema, 
imaging techniques like high-resolution cutaneous ultrasonography and magnetic 
resonance imaging showed no defects in the lymphatic system in early stages [24, 
41–43]. Other methods have also been successfully used to differentiate lipedema 
from lymphedema which includes tissue dielectric constant and dual-energy X-ray 
absorptiometry techniques [44–48].
Dysfunction of lymphatic vessels results in accumulation of interstitial fluid 
(edema) in adipose tissues triggering inflammation by the recruitment of mac-
rophages resulting in fibrosis and difficulty with weight loss. As a consequence, 
adipose tissue loses its elasticity suggesting that lipedema might be a connective 
tissue disorder [15, 49]. Studies have also indicated that edema might induce growth 
of lipedema fat as well as hypoxia resulting in adipocyte cell death [50].
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Further, morphologic changes in lymphatic vessels and accumulation of inter-
stitial fluid are present in some women with lipedema, with no change in transport 
of lymphatic fluid, which suggests these individuals might have a higher risk of 
progressing to lipo-lymphedema especially in advanced stages of lipedema [15, 51]. 
Accurate diagnosis of lipedema in association with lymphedema is essential for 
treating and following up of lipedema patients.
4. Pathophysiology of the disease
Hormones, genetic factors, leaky blood vessels, dysfunctional lymphatics sys-
tem, inflammation, hypertrophic adipocytes and interstitial thickening are among 
the factors that contribute to the pathogenesis of lipedema [10, 12, 15].
4.1 Hormones
Hormones play an essential role in the etiology of the lipedema, but how they 
affect the metabolism and function of adipocytes function is still unknown. Studies 
have shown that hormones, like estrogen and progesterone, have a direct effect on 
lipogenesis, insulin levels and adipose tissue distribution in the body. Dysregulation 
of hormonal levels lead to fat dysregulation, impairment of the lipogenesis-lipolysis 
mechanism, hypertension, insulin resistance and hyperinsulinemia [13, 52, 53]. 
Hormones might also have an impact on the nervous system which might explain 
the pain experienced by lipedema patients. Szél et al. hypothesized that alteration in 
estrogen (or estrogen receptors) maybe involved in the pathogenesis of lipedema by 
suggesting a link between accumulation of adipose tissue, imbalanced estrogen levels 
and inflammation of the peripheral and sympathetic nerves of the disease [13].
4.2 Adipocytes, immune cells and blood vessels
Lipedema fat tissue is characterized by hypertrophic adipocytes, inflammatory 
immune cells, dilation of subdermal blood and lymphatic vessels. We and others 
have shown a high number of infiltrating macrophages in lipedema adipose tissue 
detected by the CD68 marker and observed as around blood vessels or as crown-like 
structures surrounding necrotic adipocytes. In addition to macrophages, mast cells 
and T-lymphocytes were detected in hyper-vascular areas mainly around blood 
vessels in lipedema fat tissue which might contribute to capillary permeability and 
accumulation of interstitial fluid [15, 16, 54].
An article published in 2004 by Taylor et al. showed that accumulation of mast 
cells in lipedema tissue contributed to increased interstitial fluid, deterioration of adi-
pocytes and potentially elastic fiber fragmentation due to the release of elastase [55], 
confirming that lipedema is a connective tissue disorder. Adding to that, direct cell-
cell interaction between hypertrophic adipocyte and macrophages as well as secreted 
paracrine factors such as vascular endothelial growth factor (VEGF), a marker of 
angiogenesis, previously reported in the blood of women with lipedema [56] might 
be associated with increase in the number of blood vessels, dilation of capillaries, 
hypoxia, inflammation and tissue fibrosis found in lipedema patients [15, 18, 57].
5. Is there a role of adipose-derived stem cells (ASC) in lipedema?
Adipose tissue-derived stem cells are widely studied for their immunomodula-
tory, anti-inflammatory, anti-fibrotic, anti-apoptotic and pro-angiogenic effects 
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[58–60], but how ASCs contribute to the development of lipedema has not been 
investigated yet. Due to their high therapeutic potential, ASCs are now considered 
an indispensable tool in regenerative medicine [61–64]. Studies have shown the 
successful treatment with ASCs for many disease including graft-versus-host dis-
ease [65], wound healing [66], cardiovascular [67], inflammatory bowel disease 
[68], diabetes mellitus [69] and several injuries including kidney and spinal cord 
[70], bone and craniofacial reconstruction [71, 72], liver cirrhosis [73], multiple 
sclerosis [74]. In addition to their self-renewal ability, ASCs have the ability to dif-
ferentiate into multiple lineages, including adipocytes, osteoblasts, chondrocytes, 
and endothelial cells [75, 76]. Thus, ASCs might play a role in lipedema adiposity 
by inducing the expansion and differentiation of progenitor adipose-derived 
stem/progenitor cells (pre-adipocytes) into mature adipocytes (hyperplasia). 
Suga el at. have shown an increase in proliferation of adipose-derived stem/pro-
genitor cell proliferation using Ki67 and CD34 markers suggesting an increase in 
adipogenesis, hypoxia, and adipocyte necrosis, at least in one case [16].
Adding to that, inflammatory cytokines secreted by hypertrophic adipocytes 
and factors in the interstitial fluid could stimulate ASC differentiation into mature 
adipocytes. Alternatively, ASCs produce a plethora of pro- and anti-inflammatory 
cytokines that might contribute to angiogenesis and inflammation resulting in leaky 
and fragile blood vessels [77, 78]. Priglinger et al. have characterized lipedema ASCs 
isolated from liposuction samples and showed an increasing number of endothe-
lial/pericytic cells using CD146 marker in lipedema patients compared to healthy 
individuals proposing that this increase might be a marker of repair of leaky blood 
and lymphatic vessels in lipedema tissues [54].
Although, ASCs might induce adipogenesis in lipedema an in-depth character-
ization of ASCs is required to confirm this theory. Otherwise, if ASCs prove to have 
anti-inflammatory, anti-fibrotic or pro-angiogenic effects, then they might be used 
to lessen tissue damage caused by leaky vessels; hence autologous treatment might 
be a promising tool for lipedema patients.
6. Conclusion
Lipedema is a painful fat disease that should be differentiated from obesity 
and lymphedema. It is the responsibility of the healthcare provider to determine 
the accurate diagnosis of the disease for successful treatment and management. 
Liposuction, hands-on therapy, exercise, and a healthy eating plan are recom-
mended for lipedema patients. Although the etiology of lipedema is complicated, 
hypertrophic adipocytes, inflammatory cytokines, and macrophages, hypoxia, 
leaky vessels and accumulation of interstitial fluid contribute to the pathogenesis of 
the disease and may also help guide treatment.
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